Esprit Pharma is niche oriented pharmaceutical company focused on specialty therapeutics to improve patient outcomes in the urology therapeutic area. The company focuses on exploring and identifying opportunities to selectively acquire and enhance the market potential of novel, commercially available therapeutics and late-stage development drugs addressing the needs of its market space.
